For his work in 2024, AbbVie helmsman Robert Michael—who took over the CEO post from Richard Gonzalez on July 1—collected roughly $18.5 million in total pay. The figure was a $4 million jump over the sum he earned in 2023,
read moreTenpoint Therapeutics has tasked Carol Kearney with cracking a market that confounded AbbVie. As the biotech’s newly appointed chief commercial officer, Kearney will oversee preparations to launch a rival to AbbVie’s age-related blurry near vision product Vuity. More: With AbbVie
read moreAt its sprawling manufacturing complex in Durham, N.C., Merck has opened a new $1 billion plant slated to produce megablockbuster HPV vaccine Gardasil. More: Merck opens B Gardasil manufacturing facility in North Carolina Source: fierce
read moreThe deal, which is expected to close in mid-2025, marks the divestiture of Endo’s international pharmaceuticals business. More: Knight Therapeutics stacks its Canadian armor with M Paladin buy Source: fierce
read more
CervoMed’s therapy demonstrates significant improvement in patients More: Dementia drug neflamapimod shows positive phase 2b trial results Source: News
read more
Oxford Medical Products targets overweight individuals More: New weight-loss pill shows promising results Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals